Alexandria Real Estate Equities/$ARE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Alexandria Real Estate Equities

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Ticker

$ARE

Primary listing

NYSE

Industry

Health Care REITs

Employees

552

ISIN

US0152711091

ARE Metrics

BasicAdvanced
$12B
92.91
$0.76
1.29
$5.24
7.45%

What the Analysts think about ARE

Analyst ratings (Buy, Hold, Sell) for Alexandria Real Estate Equities stock.

Bulls say / Bears say

Alexandria Real Estate Equities has a robust development pipeline of approximately 7.0 million square feet, with over half pre-leased, indicating strong future revenue streams. (Investing.com)
The company reported a 48% increase in leasing activity compared to the trailing twelve-month average, suggesting resilience and demand in the life sciences sector. (Investing.com)
Alexandria maintains a strong balance sheet with $5.7 billion in liquidity and a net debt to gross real estate ratio of 27%, providing financial flexibility for growth initiatives. (Investing.com)
The life sciences real estate market is experiencing supply headwinds, which could pressure occupancy rates and rental growth in the short term. (Investing.com)
Capital market constraints for biotech firms may lead potential tenants to delay expansion plans, impacting leasing velocity and rental rates. (Investing.com)
The company's low Altman Z-score and declining operational efficiency metrics suggest potential financial distress, raising concerns about its long-term viability. (GuruFocus)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.

ARE Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ARE Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ARE

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jun30
Alexandria Real Estate Equities
Dividend·Ex-dividend
Jul15
Alexandria Real Estate Equities
Dividend·Payment
$1.32Per share
FAQs